Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Memorial Sloan Kettering Cancer Center · Providence Portland Medical Center · +12 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,543
total citations
- FWCI
- 63.58
- Percentile
- 100%
- References
- 76
Citations per year
Authors
25Topics & keywords
Topics
Keywords
- Nivolumab
- Ipilimumab
- Biology
- Transcriptome
- Immune checkpoint
- Immunotherapy
- Exome sequencing
- T-cell receptor
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.